Food and Drug Administration’s approval hands drugmaker Novo Nordisk an edge in the race to market an obesity pill US regulators on Monday gave the green light to a pill version of the blockbuster ...
Novo Nordisk remains a Strong Buy despite recent earnings misses, trial setbacks, and competitive pressures in the weight loss/diabetes market. NVO's valuation is compelling, trading at a low P/E of ...
Novo Nordisk's trial to treat Alzheimer's with its GLP-1 drug failed. The company has been losing market share to Eli Lilly. Novo Nordisk also lost a bidding war for a promising start-up. Novo Nordisk ...
Novo Nordisk NOVO.B-2.92%decrease; red down pointing triangle filed for U.S. approval of a higher dose of its Wegovy weight-loss injection, with a decision expected within a month or two. The Danish ...
Novo Nordisk said on Monday an older oral version of its semaglutide drug failed to meet its main goal in late-stage trials testing whether the medicine can slow cognitive decline in Alzheimer’s ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Within the next two weeks ...
Novo Nordisk is cutting the out-of-pocket prices of its popular weight-loss drug Wegovy and diabetes drug Ozempic for some consumers. Current customers who pay for the drugs out of pocket — without ...
Novo Nordisk has reported the mixed midphase results behind its push to enter a heart disease market served by Alnylam Pharmaceuticals, BridgeBio and Pfizer. The phase 2 trial compared two doses of ...
COPENHAGEN (Reuters) -Denmark's Novo Nordisk said on Thursday it has made an unsolicited bid for U.S. drug maker Metsera, after Pfizer in September made an offer for the company. Novo said it had ...
No callers are identified. No conversations are recorded. No phone records are kept. Now speak clearly and when you are finished say: 'Go ahead'.
Hosted on MSN
NOVO CRETA 2025: PREÇOS, MOTOR 1.6 TURBO E MAIS
A Hyundai acaba de revelar o Creta 2025. Linha atualizada do suv mais vendido no Brasil (no varejo) conta com cinco versões e a nova motorização 1.6 turbo a gasolina. Também mudam os designs externo e ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results